Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02605187 · ClinicalTrials.gov registry record · NA
Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT02605187: Completed NA study, sponsored by Stanford University.
NCT02605187 is a NA study that has completed, run by Stanford University. The registered enrollment target is 160 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02605187, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
The ability to predict pain and then apply modified treatment protocols has been limited. Current practice is for physicians to select standard post-operative pain treatment protocols without patient consultation. This study hopes to determine if patient's involvement in analgesic drug/dosage selection can optimize pain relief while minimizing related side effects. This could result in a more patient-centered care model and individualized perioperative analgesic treatment protocols based on patient's preferences, needs and expectations.
Primary Outcome
Opioid consumption was measured in milligram morphine equivalents in the 0-24 and 24-48 hour study periods.
Interventions
- DRUG Acetaminophen
- DRUG Ibuprofen
- DRUG Gabapentin
- OTHER No choice given
- OTHER Choice given
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2015-11 |
| Est. Completion | 2017-05-22 |
| Phase | NA |
What the finished NCT02605187 record still lists
NCT02605187 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 5 interventions - of which Acetaminophen is the first listed.
NCT02605187 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02605187 about?
NCT02605187 is a clinical study titled "Patient-Driven Analgesic Protocol Selection for Post-Cesarean Pain Management". The ability to predict pain and then apply modified treatment protocols has been limited. Current practice is for physicians to select standard post-operative pain treatment protocols without patient consultation. This study hopes to determine if patient's involvement in analgesic drug/dosage select...
What is the current status of trial NCT02605187?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2015-11. Estimated completion is 2017-05-22.
What interventions are being tested in trial NCT02605187?
The interventions under investigation include: Acetaminophen (DRUG), Ibuprofen (DRUG), Gabapentin (DRUG), No choice given (OTHER), Choice given (OTHER).
Who is sponsoring clinical trial NCT02605187?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02605187's enrollment target sits among peer trials
160 628th of 2000 higher than 1,347 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia